Skip to main content
ImmuneCited

Curcumin pour Chronic Inflammation

A

An umbrella meta-analysis of 10 studies with 5,870 participants demonstrates curcumin supplementation may significantly reduce CRP, IL-6, and TNF-alpha inflammatory markers. Piperine co-administration increases bioavailability by approximately 2,000%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

En conclusion

An umbrella meta-analysis of 10 studies with 5,870 participants demonstrates curcumin supplementation may significantly reduce CRP, IL-6, and TNF-alpha inflammatory markers. Piperine co-administration increases bioavailability by approximately 2,000%.

Key Study Findings

Review
Therapeutic potential of curcumin against pancreatitis.
Dose: None vs: None Outcome: curcumin effects on pancreatitis via anti-inflammatory and antioxidant … Effet: None None

Population: None

Review
Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.
Dose: None vs: None Outcome: None Effet: None None

Population: review of dietary polyphenols in type 2 diabetes mellitus management

Review
Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications.
Dose: None vs: None Outcome: None Effet: None None

Population: review of plant-derived anti-inflammatory compounds for chronic disease prevention

Review
Pathological interplay of NF-κB and M1 macrophages in chronic inflammatory lung diseases.
Dose: None vs: None Outcome: None Effet: None None

Population: review of NF-kB and M1 macrophages in asthma, COPD, and pulmonary fibrosis

Review
Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.
Dose: None vs: None Outcome: None Effet: None None

Population: None

Key Statistics

10

Études

5870

Participants

Positive

A

Note

Referenced Papers

Antioxidants (Basel, Switzerland) 2025 8 citations
Voprosy pitaniia 2022 1 citations
Biomedicines 2021 228 citations
Frontiers in medicine 2021 13 citations
Advances in experimental … 2021 6 citations
European journal of … 2020 91 citations
Current medicinal chemistry 2018 13 citations
Current pharmaceutical design 2017 168 citations
Molecules (Basel, Switzerland) 2015 539 citations
BioFactors (Oxford, England) 2013 288 citations
BioFactors (Oxford, England) 2013 167 citations
Current drug targets 2006 92 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
500-1,000 mg/day curcuminoids
enhancedabsorption:
150-500 mg/day (phytosome or piperine formulation)

Limite supérieure : No established UL; generally well-tolerated up to 8 g/day

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Neutral --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --

Moment optimal de prise : With meals containing fat and black pepper (piperine) for enhanced absorption

Safety & Side Effects

Effets indésirables signalés

  • Gastrointestinal discomfort (nausea, diarrhea, bloating)
  • Headache
  • Yellow stool discoloration
  • Iron absorption interference at very high doses

Interactions connues

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Diabetes medications (may enhance blood sugar lowering)
  • CYP1A2, CYP3A4, CYP2D6 substrates (may inhibit metabolism)
  • Sulfasalazine and cyclophosphamide (may modify effects)

Apport maximal tolérable : No established UL; generally well-tolerated up to 8 g/day

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Curcumin help with Chronic Inflammation?
Based on 10 studies with 5,870 participants, there is strong evidence from multiple clinical trials that Curcumin may support Chronic Inflammation management. Our evidence grade is A (Strong Evidence).
How much Curcumin should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day curcuminoids. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea, bloating), Headache, Yellow stool discoloration, Iron absorption interference at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Chronic Inflammation?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 10 peer-reviewed studies with 5,870 total participants. The overall direction of effect is positive.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.